Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Loren Lasko, Clarissa G. Jakob, Rohinton Edalji, et al.
Nature (2017) Vol. 550, Iss. 7674, pp. 128-132
Open Access | Times Cited: 656

Showing 1-25 of 656 citing articles:

Functions and mechanisms of non-histone protein acetylation
Takeo Narita, Brian T. Weinert, Chunaram Choudhary
Nature Reviews Molecular Cell Biology (2018) Vol. 20, Iss. 3, pp. 156-174
Closed Access | Times Cited: 930
Modulation of cellular processes by histone and non-histone protein acetylation
Maria Shvedunova, Asifa Akhtar
Nature Reviews Molecular Cell Biology (2022) Vol. 23, Iss. 5, pp. 329-349
Closed Access | Times Cited: 513
Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential
Frank Madeo, Didac Carmona‐Gutiérrez, Sebastian J. Hofer, et al.
Cell Metabolism (2019) Vol. 29, Iss. 3, pp. 592-610
Open Access | Times Cited: 502
Targeting the epigenetic regulation of antitumour immunity
Simon J. Hogg, Paul A. Beavis, Mark A. Dawson, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 11, pp. 776-800
Closed Access | Times Cited: 449
Epigenetic modifications of histones in cancer
Zibo Zhao, Ali Shilatifard
Genome biology (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 447
Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome
Brian T. Weinert, Takeo Narita, Shankha Satpathy, et al.
Cell (2018) Vol. 174, Iss. 1, pp. 231-244.e12
Open Access | Times Cited: 417
Epigenetic mechanisms in breast cancer therapy and resistance
Liliana Garcia-Martinez, Yusheng Zhang, Yuichiro Nakata, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 331
MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy
Annelisa M. Cornel, Iris Mimpen, Stefan Nierkens
Cancers (2020) Vol. 12, Iss. 7, pp. 1760-1760
Open Access | Times Cited: 324
Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study
Kuniko Sunami, Hitoshi Ichikawa, Takashi Kubo, et al.
Cancer Science (2019) Vol. 110, Iss. 4, pp. 1480-1490
Open Access | Times Cited: 314
Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics
Ibraheem Ali, Ryan J. Conrad, Eric Verdin, et al.
Chemical Reviews (2018) Vol. 118, Iss. 3, pp. 1216-1252
Open Access | Times Cited: 302
Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation
Ryan Raisner, Samir Kharbanda, Lingyan Jin, et al.
Cell Reports (2018) Vol. 24, Iss. 7, pp. 1722-1729
Open Access | Times Cited: 302
Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
Yang Gao, Naoe Taira Nihira, Xia Bu, et al.
Nature Cell Biology (2020) Vol. 22, Iss. 9, pp. 1064-1075
Open Access | Times Cited: 272
CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities
Kyuho Han, Sarah E. Pierce, Amy Li, et al.
Nature (2020) Vol. 580, Iss. 7801, pp. 136-141
Open Access | Times Cited: 262
Advances in targeting ‘undruggable’ transcription factors with small molecules
Matthew J. Henley, Angela N. Koehler
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 9, pp. 669-688
Closed Access | Times Cited: 258
Recent Advances in Prostate Cancer Treatment and Drug Discovery
Ekaterina Nevedomskaya, Simon J. Baumgart, Bernard Haendler
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 5, pp. 1359-1359
Open Access | Times Cited: 232
Transcriptional and Epigenomic Regulation of Adipogenesis
Ji‐Eun Lee, Hannah Schmidt, Binbin Lai, et al.
Molecular and Cellular Biology (2019) Vol. 39, Iss. 11
Open Access | Times Cited: 230
The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination
Florian Wimmers, Michele Donato, Alex Kuo, et al.
Cell (2021) Vol. 184, Iss. 15, pp. 3915-3935.e21
Open Access | Times Cited: 210
Targeting the p300/CBP Axis in Lethal Prostate Cancer
Jonathan Welti, Adam Sharp, Nigel Brooks, et al.
Cancer Discovery (2021) Vol. 11, Iss. 5, pp. 1118-1137
Open Access | Times Cited: 198
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
Theresa E. Hickey, Luke A. Selth, Kee Ming Chia, et al.
Nature Medicine (2021) Vol. 27, Iss. 2, pp. 310-320
Open Access | Times Cited: 187
Evaluating Enhancer Function and Transcription
Andrew R. Field, Karen Adelman
Annual Review of Biochemistry (2020) Vol. 89, Iss. 1, pp. 213-234
Closed Access | Times Cited: 184
PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)
Ming He, Chao-Guo Cao, Zhihao Ni, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 168
p300-Mediated Lysine 2-Hydroxyisobutyrylation Regulates Glycolysis
He Huang, Shuang Tang, Ming Ji, et al.
Molecular Cell (2018) Vol. 70, Iss. 4, pp. 663-678.e6
Open Access | Times Cited: 162
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
Takeshi Namekawa, Kazuhiro Ikeda, Kuniko Horie‐Inoue, et al.
Cells (2019) Vol. 8, Iss. 1, pp. 74-74
Open Access | Times Cited: 151
Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release
Takeo Narita, Shinsuke Ito, Yoshiki Higashijima, et al.
Molecular Cell (2021) Vol. 81, Iss. 10, pp. 2166-2182.e6
Open Access | Times Cited: 151
CircMRPS35 suppresses gastric cancer progression via recruiting KAT7 to govern histone modification
Mengmeng Jie, Yaran Wu, Mengyuan Gao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 149
Page 1 - Next Page

Scroll to top